腫瘍性MYCによる活性化と抑制は,腫瘍特異的な遺伝子発現プロフィールを形作る
Susanne Walz1, Francesca Lorenzin1, Jennifer Morton2
11] Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany [2].
Nature
|July 22, 2014
まとめ
MYCのオンコタンパク質は,MYCのオンコタンパク質である.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 遺伝子規制 遺伝子規制
背景:
- MYCオンコタンパク質は,哺乳類の細胞における遺伝子発現の重要な調節剤である.
- MYCの過剰発現は,遺伝子発現プロフィールを変化させ,様々な癌に関与しています.
- 腫瘍細胞と正常細胞におけるMYCの役割を理解することは,がん治療において極めて重要です.
研究 の 目的:
- 腫瘍細胞におけるMYCによって引き起こされる特定の遺伝子発現の変化を,正常細胞と比較して調査する.
- MYCの遺伝子発現の文脈依存的調節の基礎となるメカニズムを解明する.
- MYC駆動腫瘍における異なった遺伝子発現シグネチャに寄与する要因を特定する.
主な方法:
- 人間の細胞系におけるMYCの誘導表現と枯渇.
- MYCの効果を in vivo で研究するために,ネズミの腫瘍モデルを使用しました.
- プロモーターにおけるMYC占有率とその遺伝子発現の変化との相関を分析した.
- トランスクリプションの開始と延長におけるMYCの役割を調査した.
- MYC媒介による遺伝子抑制におけるMIZ1 (ZBTB17) の役割を調べました.
主要な成果:
- MYCレベルは,腫瘍細胞の特徴である特定の遺伝子活性化と抑制パターンを決定する.
- MYCプロモーターの占有率とEボックス配列の親和性は,遺伝子応答の大きさと方向と相関しています.
- MYCは,トランスクリプションの開始と延長の両方に影響を及ぼし,異なる標的遺伝子に明確な影響を及ぼします.
- MIZ1による複合形成は,MYCによる遺伝子抑制を媒介し,MYC/MIZ1比が結果を決定する.
結論:
- MYCの腫瘍性機能は,標的遺伝子発現の特定の変化から生じ,単なる広範な遺伝子活性化から生じません.
- プロモーターの親和性,転写開始の調節,MIZ1複合体の形成は,MYCの特異性の重要な決定因子である.
- これらの発見は,腫瘍発生におけるMYCの役割と,MYCを標的とした潜在的な治療戦略についての洞察を提供します.
関連する概念動画
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer-Critical Genes I: Proto-oncogenes
5.8K
5.8K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression
1.5K
1.5K


